St. Jude Medical Announces Third Quarter Dividend

  St. Jude Medical Announces Third Quarter Dividend  Board declares third quarter dividend of $0.27 per share  Business Wire  ST. PAUL, Minn. -- July 29, 2014  St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its board of directors declared a third quarter dividend of $0.27 per common share. This dividend amount is equal to the dividend paid during the first and second quarters of 2014 and brings the total dividend declared for the year to $0.81 per share. The dividend is payable October 31, 2014, to shareholders of record on September 30, 2014.  About St. Jude Medical  St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive, epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit or follow us on Twitter @StJudeMedicalIR.  Forward-Looking Statements  This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2013 and Quarterly Report on Form 10-Q for the fiscal quarter ended March 29, 2014. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.  Contact:  St. Jude Medical, Inc. J.C. Weigelt, 651-756-4347 Investor Relations  
Press spacebar to pause and continue. Press esc to stop.